Back to state act
Description
On 7 June 2021, Pakistan's Federal Board of Revenue through SRO 751(I)/2021 reduced the maximum duty drawback on the exports of pharmaceutical suspensions from 1.15% to 0.30% of the FOB value. The dra...
Sign in to see full description
Intervention Details
Intervention Type
Tax-based export incentive
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
07 Jun 2021
Revocation date
No revocation date
Implementation level
National
Affected flow
Outward subsidy
Announced as temporary
No
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 6 products
Threads
See all
This intervention is not part of any Thread yet.